CNC / Centene Corporation - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Centene Corporation
US ˙ NYSE ˙ US15135B1017

Mga Batayang Estadistika
LEI 549300Z7JJ4TQSQGT333
CIK 1071739
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Centene Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
August 15, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 CENTENE CORPORATI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Nu

August 4, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2025 CENTENE CORPORATIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

July 25, 2025 EX-99.1

CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS -- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Sara Garland Senior Vice President, Finance & Investor Relations Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS - Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) - ST. LOUIS

July 25, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

July 25, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2025 CENTENE CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

July 25, 2025 EX-10.3

Centene Corporation Non-Employee Director Deferred Stock Compensation Plan.

EXHIBIT 10.3 CENTENE CORPORATION NON-EMPLOYEE DIRECTORS DEFERRED STOCK COMPENSATION PLAN As amended and restated as of May 13, 2025 ARTICLE I INTRODUCTION I.1 Establishment. Centene Corporation (the “Company”) hereby establishes the Centene Corporation Non-Employee Directors Deferred Stock Compensation Plan, as amended and restated (the “Plan”) for those directors of the Company who are not employ

July 25, 2025 EX-10.1

Non-Employee Director Compensation Policy

EXHIBIT 10.1 CENTENE CORPORATION Non-Employee Director Compensation Policy as of May 13, 2025 This Non-Employee Director Compensation Policy (the “Policy”) sets forth the compensation to be paid to non-employee members (“Non-Employee Directors”) of the Board of Directors (the “Board”) of Centene Corporation (the “Company”), which shall remain in effect until amended, replaced or rescinded by furth

July 25, 2025 EX-10.2

Form of Non-Employee Director Restricted Stock Unit Agreement #1

EXHIBIT 10.2 CENTENE CORPORATION Form of Restricted Stock Unit Agreement Granted Under 2025 Stock Incentive Plan THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Company desires to align the long-term interests of its directors with those of the Company by providing the ownership interest

July 1, 2025 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

July 1, 2025 EX-99.1

CENTENE CORPORATION WITHDRAWS 2025 GUIDANCE

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Sara Garland Senior Vice President, Finance & Investor Relations Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION WITHDRAWS 2025 GUIDANCE ST. LOUIS, July 1, 2025 - Centene Corporation (NYSE: CNC) (Centene, the Company) is withdrawing its pre

May 19, 2025 EX-99.2

CENTENE CORPORATION NON-EMPLOYEE DIRECTORS DEFERRED STOCK COMPENSATION PLAN As amended and restated ARTICLE I

Exhibit 99.2 CENTENE CORPORATION NON-EMPLOYEE DIRECTORS DEFERRED STOCK COMPENSATION PLAN As amended and restated ARTICLE I INTRODUCTION I.1 Establishment. Centene Corporation (the “Company”) hereby establishes the Centene Corporation Non-Employee Directors Deferred Stock Compensation Plan, as amended and restated (the “Plan”) for those directors of the Company who are not employees of the Company

May 19, 2025 S-8

As filed with the Securities and Exchange Commission on May 19, 2025

As filed with the Securities and Exchange Commission on May 19, 2025 Registration No.

May 19, 2025 EX-FILING FEES

Table 1: Newly Registered Securities

Calculation of Filing Fee Tables S-8 CENTENE CORP Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.

May 14, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025 CENTENE CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

May 6, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number

April 25, 2025 EX-10.1

Form of Restricted Stock Unit Agreement #1

EXHIBIT 10.1 CENTENE CORPORATION Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as defined below) of

April 25, 2025 EX-10.2

Form of Performance Based Restricted Stock Unit Agreement #1

EXHIBIT 10.2 CENTENE CORPORATION Performance-Based Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as

April 25, 2025 EX-10.3

Performance Based Restricted Stock Unit Agreement for Andrew Asher

EXHIBIT 10.3 CENTENE CORPORATION Performance-Based Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as

April 25, 2025 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

April 25, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

April 25, 2025 EX-19.1

Policy on Inside Information and Insider Trading

EXHIBIT 19.1 CENTENE CORPORATION Policy on Inside Information and Insider Trading I.BACKGROUND/PURPOSE: Under federal and state securities laws, it is illegal to purchase or sell securities of a company while in possession of material, non-public information related to, affecting or regarding that company or its subsidiaries (such information, “Inside Information”), or to disclose Inside Informati

April 25, 2025 EX-99.1

CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS -- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Isabella Wiltse Senior Vice President, Finance & Investor Relations Vice President, Media & Public Relations (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS - Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 - •First quarter 2025 a

April 14, 2025 PX14A6G

Notice of Exempt Solicitation Pursuant to Rule 14a-103 Name of Registrant: Centene (CNC) Name of person relying on exemption: As You Sow® Address of persons relying on exemption: 11461 San Pablo Ave, Suite 400, El Cerrito, CA 94530 The attached writt

Notice of Exempt Solicitation Pursuant to Rule 14a-103 Name of Registrant: Centene (CNC) Name of person relying on exemption: As You Sow® Address of persons relying on exemption: 11461 San Pablo Ave, Suite 400, El Cerrito, CA 94530 The attached written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exchange Act of 1934.

April 11, 2025 PX14A6G

Vote “Yes” on Shareholder Proposal #5

Notice of Exempt Solicitation Pursuant to Rule 14a-103 Name of Registrant: Centene Corporation (CNC) Name of person relying on exemption: John Chevedden, Centene Shareholder since 2019 Address of persons relying on exemption: POB 2673, Redondo Beach, CA 90278 These written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exchange Act of 1934.

March 27, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin

March 27, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

March 12, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

March 5, 2025 EX-10.1

, 2025, by and among Centene Corporation, the lenders from time to time party thereto and Wells Fargo Bank, National Association, as the administrative agent for the lenders.

EXHIBIT 10.1 Published CUSIP Number: 15135NAN5 Revolving Credit CUSIP Number: 15135NAP0 Term Loan CUSIP Number: 15135NAQ8 $6,000,000,000 CREDIT AGREEMENT dated as of March 5, 2025, by and among CENTENE CORPORATION, as Borrower, the Lenders referred to herein, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, Swingline Lender and Issuing Lender WELLS FARGO SECURITIES,

March 5, 2025 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

March 3, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

February 24, 2025 EX-99.1

CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Isabella Wiltse Senior Vice President, Finance & Investor Relations Vice President, Media & Public Relations (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS ST. LOUIS, February 24, 2025 - Centene Corporation (NYSE: CNC) ("the Company

February 24, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2025 CENTENE CORPORA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

February 18, 2025 EX-10.9

Form of Non-Employee Director Compensation Policy

EXHIBIT 10.9 CENTENE CORPORATION Non-Employee Director Compensation Policy This Non-Employee Director Compensation Policy (the “Policy”) sets forth the compensation to be paid to non-employee members (“Non-Employee Directors”) of the Board of Directors (the “Board”) of Centene Corporation (the “Company”), which shall remain in effect until amended, replaced or rescinded by further action of the Bo

February 18, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 Centene Corpor

February 18, 2025 EX-19.1

Policy on Inside Information and Insider Trading

EXHIBIT 19.1 CENTENE CORPORATION Policy on Inside Information and Insider Trading I.BACKGROUND/PURPOSE: Under federal and state securities laws, it is illegal to purchase or sell securities of a company while in possession of material, non-public information related to, affecting or regarding that company or its subsidiaries (such information, “Inside Information”), or to disclose Inside Informati

February 18, 2025 EX-21

List of subsidiaries

EXHIBIT 21 List of Subsidiaries as of December 31, 2024 Absolute Total Care, Inc, a South Carolina corporation AcariaHealth Pharmacy #11, Inc, a Texas corporation AcariaHealth Pharmacy #12, Inc, a New York corporation AcariaHealth Pharmacy #13, Inc, a California corporation AcariaHealth Pharmacy #14, Inc, a California corporation AcariaHealth Pharmacy #26, Inc, a Delaware corporation AcariaHealth Pharmacy, Inc, a California corporation AcariaHealth, Inc.

February 4, 2025 EX-99.1

CENTENE CORPORATION REPORTS 2024 RESULTS -- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Isabella Wiltse Senior Vice President, Finance & Investor Relations Vice President, Media & Public Relations (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS 2024 RESULTS - 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 - •2024 adjusted dilut

February 4, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2025 CENTENE CORPORAT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

December 12, 2024 EX-99.1

CENTENE CORPORATION ANNOUNCES 2025 GUIDANCE -- 2025 adjusted diluted EPS of greater than $7.25 -- -- Reaffirms 2024 adjusted diluted EPS guidance of greater than $6.80 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Isabella Wiltse Senior Vice President, Finance & Investor Relations Vice President, Media & Public Relations (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION ANNOUNCES 2025 GUIDANCE - 2025 adjusted diluted EPS of greater than $7.25 - - Reaffirms 2024 adjusted diluted EP

December 12, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

November 14, 2024 SC 13G

CNC / Centene Corporation / HARRIS ASSOCIATES L P Passive Investment

SC 13G 1 formsc13g-11142024091157.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Centene Corp (Name of Issuer) Common Stock $0.001 Par Value (Title of Class of Securities) 15135B101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r

November 13, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

November 13, 2024 SC 13G/A

CNC / Centene Corporation / Capital World Investors - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* Centene Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 15135B101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desi

November 12, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

October 25, 2024 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

October 25, 2024 EX-99.1

CENTENE CORPORATION REPORTS THIRD QUARTER 2024 RESULTS -- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Isabella Wiltse Senior Vice President, Finance & Investor Relations Vice President, Media & Public Relations (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS THIRD QUARTER 2024 RESULTS - Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 - - Reaffirms 2024 Adju

October 25, 2024 EX-10.1

Executive Severance and Change in Control Plan

EXHIBIT 10.1 CENTENE CORPORATION AMENDED AND RESTATED EXECUTIVE SEVERANCE AND CHANGE IN CONTROL PLAN (and Summary Plan Description) for Eligible Employees I.PURPOSE This Centene Corporation Amended and Restated Executive Severance and Change in Control Plan (the “Executive Plan”) is intended to provide benefits to Eligible Employees of Centene Corporation and its United States based subsidiaries (

October 25, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

October 11, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

October 3, 2024 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation)

September 27, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

September 16, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

September 10, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2024 CENTENE CORPOR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

August 15, 2024 EX-99.1

CENTENE ANNOUNCES THE ELECTION OF THOMAS GRECO TO BOARD OF DIRECTORS

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Shannon Susko Senior Vice President, Finance & Investor Relations Senior Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE ANNOUNCES THE ELECTION OF THOMAS GRECO TO BOARD OF DIRECTORS ST. LOUIS, August 15, 2024 - Centene Corporation (NYSE

August 15, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

July 26, 2024 EX-10.2

Form of Non-Employee Director Restricted Stock Unit Agreement #1

EXHIBIT 10.2 CENTENE CORPORATION Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and [Participant Name] (hereinafter the “Participant”). WHEREAS, the Company desires to align the long-term interests of its directors with those of the Company by providing th

July 26, 2024 EX-10.1

Amended and Restated Non-Employee Directors Deferred Stock Compensation Plan

EXHIBIT 10.1 CENTENE CORPORATION NON-EMPLOYEE DIRECTORS DEFERRED STOCK COMPENSATION PLAN As amended and restated ARTICLE I INTRODUCTION I.1 Establishment. Centene Corporation (the “Company”) hereby establishes the Centene Corporation Non-Employee Directors Deferred Stock Compensation Plan, as amended and restated (the “Plan”) for those directors of the Company who are not employees of the Company

July 26, 2024 EX-99.1

CENTENE CORPORATION REPORTS SECOND QUARTER 2024 RESULTS -- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.42 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Shannon Susko Senior Vice President, Finance & Investor Relations Senior Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS SECOND QUARTER 2024 RESULTS - Diluted EPS of $2.16; Adjusted Diluted EPS of $2.42 - - Reaffirms

July 26, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2024 CENTENE CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

July 26, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

July 23, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

May 29, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

May 16, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

April 26, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

April 26, 2024 EX-99.1

CENTENE CORPORATION REPORTS FIRST QUARTER 2024 RESULTS -- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 -- -- Increases 2024 Full Year Guidance --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Shannon Susko Senior Vice President, Finance & Investor Relations Senior Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS FIRST QUARTER 2024 RESULTS - Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 - - Increases

April 26, 2024 EX-10.2

Form of Performance Based Restricted Stock Unit Agreement #1

EXHIBIT 10.2 CENTENE CORPORATION Performance-Based Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as

April 26, 2024 EX-10.1

Form of Restricted Stock Unit Agreement #1

EXHIBIT 10.1 CENTENE CORPORATION Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as defined below) of

April 26, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2024 CENTENE CORPORATIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

April 3, 2024 PX14A6G

Vote “Yes” on Shareholder Proposal #4

Centene (CNC) Shareholder Alert Voluntary submission by John Chevedden, POB 2673, Redondo Beach, CA 90278 Centene shareholder since 2019 Please Support Item #4 for Managing Climate Risk Through Science-Based Targets and Transition Planning To Centene Shareholders: I ask shareholders to vote FOR Item 4 at the Centene shareholder meeting on May 14, 2024.

March 29, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

March 29, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2024 CENTENE CORPORATIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

March 28, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide

March 28, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

March 11, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

February 21, 2024 EX-4.3

CENTENE CORPORATION DEBT SECURITIES INDENTURE Dated as of February 21, 2024 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee

Exhibit 4.3 CENTENE CORPORATION DEBT SECURITIES INDENTURE Dated as of February 21, 2024 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01. Definitions 1 Section 1.02. Other Definitions 6 Section 1.03. Incorporation by Reference of Trust Indenture Act 7 Section 1.04. Rules of Construction 7 ARTICLE 2 THE NOTES 8 Section 2.

February 21, 2024 S-3ASR

As filed with the Securities and Exchange Commission on February 21, 2024

Table of Contents As filed with the Securities and Exchange Commission on February 21, 2024 Registration No.

February 21, 2024 EX-25.1

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION D

Exhibit 25.1 = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) || THE BANK OF NE

February 21, 2024 EX-FILING FEES

Calculation of Filing Fee Tables Form S-3 (Form Type) Centene Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Centene Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule(1) Amount Registered(2) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate(1) Amount of Registration Fee(1) Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid Debt Debt Securities Rule 456(b) and 457(r) Equity Common Stock, par value $0.

February 20, 2024 EX-21

List of subsidiaries

EXHIBIT 21 List of Subsidiaries as of December 31, 2023 ABC Network & Collaborative Health Systems Joint Venture, LLC, an Arizona LLC Absolute Total Care, Inc, a South Carolina corporation AcariaHealth Pharmacy #11, Inc, a Texas corporation AcariaHealth Pharmacy #12, Inc, a New York corporation AcariaHealth Pharmacy #13, Inc, a California corporation AcariaHealth Pharmacy #14, Inc, a California corporation AcariaHealth Pharmacy #26, Inc, a Delaware corporation AcariaHealth Pharmacy, Inc, a California corporation AcariaHealth, Inc.

February 20, 2024 EX-4.1

Description of Securities of the Company

EXHIBIT 4.1 DESCRIPTION OF CENTENE COMMON STOCK Authorized Capital Stock of Centene The Centene amended and restated certificate of incorporation provides that the total number of shares of capital stock which may be issued by Centene is 810,000,000, consisting of 800,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share. V

February 20, 2024 EX-10.9

Executive Severance and Change in Control Plan

EXHIBIT 10.9 CENTENE CORPORATION EXECUTIVE SEVERANCE AND CHANGE IN CONTROL PLAN (and Summary Plan Description) for Eligible Executives I.PURPOSE This Centene Corporation Executive Severance and Change in Control Plan (the "Executive Plan") is intended to provide benefits to eligible employees of Centene Corporation and its United States based subsidiaries (collectively, the "Company"), who become

February 20, 2024 EX-10.31

Executive Restricted Covenant Agreement

EXHIBIT 10.31 CENTENE CORPORATION Restrictive Covenant Agreement Pursuant to Executive Severance and Change in Control Plan THIS AGREEMENT (“Agreement”) is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and the undersigned employee of the Company or employee of one of Company’s Affiliates (hereinafter the “Participant”). WHEREAS the Participant renders imp

February 20, 2024 EX-97

Centene Corporation Clawback Policy

EXHIBIT 97 CENTENE CORPORATION CLAWBACK POLICY The Compensation and Talent Committee (the “Committee”) of the Board of Directors (the “Board”) of Centene Corporation (the “Company”) believes that it is appropriate for the Company to adopt this Clawback Policy (the “Policy”) to be applied to the Executive Officers of the Company and adopts this Policy to be effective as of the Effective Date.

February 20, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 Centene Corpor

February 20, 2024 EX-10.5

Amended and Restated Voluntary Nonqualified Deferred Compensation Plan

EXHIBIT 10.5 Seventh Amendment and Restatement of the Centene Corporation Voluntary Nonqualified Deferred Compensation Plan ARTICLE I PURPOSE AND EFFECTIVE DATE The purpose of the Centene Corporation Voluntary Nonqualified Deferred Compensation Plan (“Plan”) is to aid Centene Corporation and its subsidiaries in retaining and attracting executive employees by providing them with tax deferred saving

February 13, 2024 SC 13G/A

CNC / Centene Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0565-centenecorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Centene Corp Title of Class of Securities: Common Stock CUSIP Number: 15135B101 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule

February 9, 2024 SC 13G/A

CNC / Centene Corporation / Capital World Investors - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Centene Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 15135B101 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig

February 6, 2024 EX-99.1

CENTENE CORPORATION REPORTS 2023 RESULTS -- 2023 Full Year Diluted EPS of $4.95; Adjusted Diluted EPS of $6.68 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Shannon Susko Senior Vice President, Finance & Investor Relations Senior Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS 2023 RESULTS - 2023 Full Year Diluted EPS of $4.95; Adjusted Diluted EPS of $6.68 - •2023 adjus

February 6, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2024 CENTENE CORPORAT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

December 13, 2023 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

December 13, 2023 EX-3.1

Amended and Restated By-laws of Centene Corporation,

Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF CENTENE CORPORATION A Delaware Corporation Effective December 8, 2023 TABLE OF CONTENTS ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 1. Place of Meetings 1 Section 2. Annual Meetings 1 Section 3. Special Meetings 1 Section 4. Quorum; Adjournment 6 Section 5. Proxies 6 Section

December 12, 2023 EX-99.1

CENTENE CORPORATION ANNOUNCES 2024 GUIDANCE

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Shannon Susko Senior Vice President, Finance & Investor Relations Senior Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION ANNOUNCES 2024 GUIDANCE •2024 adjusted diluted EPS of greater than $6.70. •Board authorizes $4.0 billio

December 12, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2023 CENTENE CORPORA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

November 15, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2023 CENTENE CORPORA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

November 15, 2023 EX-99.1

Contacts: Media Inquiries Investors Shannon Susko Jennifer Gilligan (314) 445-0790 (212) 549-1306 [email protected] [email protected]

Exhibit 99.1 N E W S R E L E A S E Contacts: Media Inquiries Investors Shannon Susko Jennifer Gilligan (314) 445-0790 (212) 549-1306 [email protected] [email protected] FOR IMMEDIATE RELEASE CENTENE CORPORATION ANNOUNCES NEW CHIEF OPERATING OFFICER ST. LOUIS, November 15, 2023 – Centene Corporation (NYSE: CNC) ("the Company"), a leading healthcare enterprise committed to helping peopl

October 24, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

October 24, 2023 EX-99.1

CENTENE CORPORATION REPORTS THIRD QUARTER 2023 RESULTS -- Diluted EPS of $0.87; Adjusted Diluted EPS of $2.00 -- -- Increases 2023 Full Year Guidance --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Shannon Susko Senior Vice President, Finance & Investor Relations Senior Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS THIRD QUARTER 2023 RESULTS - Diluted EPS of $0.87; Adjusted Diluted EPS of $2.00 - - Increases

October 24, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023 CENTENE CORPORAT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

October 16, 2023 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

September 6, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2023 CENTENE CORPORA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

July 28, 2023 EX-10.1

Form of Restricted Stock Agreement (Directors) #2

EXHIBIT 10.1 CENTENE CORPORATION Restricted Stock Agreement Granted Under 2012 Stock Incentive Plan THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and the undersigned Director of the Company (hereinafter the “Participant”). WHEREAS, the Company desires to align the long-term interests of its directors with those of the Company by providin

July 28, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

July 28, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2023 CENTENE CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

July 28, 2023 EX-99.1

CENTENE CORPORATION REPORTS SECOND QUARTER 2023 RESULTS -- Diluted EPS of $1.92; Adjusted Diluted EPS of $2.10 -- -- Increases 2023 Full Year Guidance --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Shannon Susko Senior Vice President, Finance & Investor Relations Senior Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS SECOND QUARTER 2023 RESULTS - Diluted EPS of $1.92; Adjusted Diluted EPS of $2.10 - - Increases

June 6, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2023 CENTENE CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

June 6, 2023 EX-10.1

First Amendment to the Fourth Amended and Restated Credit Agreement, dated as of May 31, 2023, by and among Centene Corporation, the several banks and other financial institutions party thereto, and Wells Fargo Bank, National Association, as the administrative agent.

Exhibit 10.1 EXECUTION VERSION FIRST AMENDMENT TO FOURTH AMENDED AND RESTATED CREDIT AGREEMENT This FIRST AMENDMENT TO FOURTH AMENDED AND RESTATED CREDIT AGREEMENT (this “First Amendment”) is made as of May 31, 2023, by and among CENTENE CORPORATION, a Delaware corporation (the “Company”), the several banks and other financial institutions or entities party hereto, and WELLS FARGO BANK, NATIONAL A

May 22, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2023 CENTENE CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

May 15, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 CENTENE CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

April 25, 2023 EX-10.2

Form of Restricted Stock Unit Agreement #4

EXHIBIT 10.2 CENTENE CORPORATION Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as defined below) of

April 25, 2023 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

April 25, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

April 25, 2023 EX-10.3

Form of Performance Based Restricted Stock Unit Agreement #3

EXHIBIT 10.3 CENTENE CORPORATION Performance-Based Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as

April 25, 2023 EX-10.1

Form of Restricted Stock Unit Agreement #3

EXHIBIT 10.1 CENTENE CORPORATION Restricted Stock Unit Agreement Granted Under 2012 Stock Incentive Plan, As Amended THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <> (hereinafter the “Participant”). WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as defined below) of

April 25, 2023 EX-99.1

CENTENE CORPORATION REPORTS FIRST QUARTER 2023 RESULTS -- Diluted EPS of $2.04; Adjusted Diluted EPS of $2.11 -- -- Increases 2023 Full Year Guidance and Updates 2024 Target --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Sandy McBride Senior Vice President, Finance & Investor Relations Vice President, Media & Public Relations (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS FIRST QUARTER 2023 RESULTS - Diluted EPS of $2.04; Adjusted Diluted EPS of $2.11 - - Increases 2023 Full Y

April 3, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini

April 3, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini

April 3, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini

March 24, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide

March 24, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

February 21, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 Centene Corpor

February 21, 2023 EX-10.22A

Amendment of Executive Employment Agreement between Centene Corporation and Sarah M. London, dated February 20, 2023

EXHIBIT 10.22a AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT (the “Amendment”) is entered into as of February 20, 2023, by and between Centene Corporation, a Delaware corporation, together with its successors and assigns permitted under this Agreement (the “Company”), and Sarah M. London (the “Executive”). WHEREAS, the parties entered into that certai

February 21, 2023 EX-10.24

Executive Employment Agreement between Centene Corporation and Kenneth Fasola, dated February 20, 2023

EXHIBIT 10.24 EXECUTIVE EMPLOYMENT AGREEMENT In this Executive Employment Agreement, dated as of February 20, 2023 (the “Agreement”), Centene Corporation (the “Company”), and Kenneth Fasola (the “Executive”), intending to be legally bound and for good and valuable consideration, agree as follows: 1.Term. a.The Executive’s employment hereunder shall begin effective on the date above and shall conti

February 21, 2023 EX-10.5

Amended and Restated Voluntary Nonqualified Deferred Compensation Plan

EXHIBIT 10.5 Sixth Amendment and Restatement of the Centene Corporation Voluntary Nonqualified Deferred Compensation Plan ARTICLE I PURPOSE AND EFFECTIVE DATE The purpose of the Centene Corporation Voluntary Nonqualified Deferred Compensation Plan ("Plan") is to aid Centene Corporation and its subsidiaries in retaining and attracting executive employees by providing them with tax deferred savings

February 21, 2023 EX-10.31

Executive Officer Cash Severance Policy

EXHIBIT 10.31 CENTENE CORPORATION EXECUTIVE OFFICER CASH SEVERANCE POLICY Purpose The purpose of this Policy is to limit the Cash Severance Benefits that Centene Corporation (the “Company”) may pay to Executive Officers upon termination. Definitions For purposes of this Policy, the following definitions shall apply: (a)“Base Salary” means the amount an Executive Officer is entitled to receive as w

February 21, 2023 EX-10.25

Executive Employment Agreement between Centene Corporation and James E. Murray, dated February 20, 2023

EXHIBIT 10.25 EXECUTIVE EMPLOYMENT AGREEMENT In this Executive Employment Agreement, dated as of February 20, 2023 (the “Agreement”), Centene Corporation (the “Company”), and James E. Murray (the “Executive”), intending to be legally bound and for good and valuable consideration, agree as follows: 1.Term. a.The Executive’s employment hereunder shall begin effective on the date above and shall cont

February 21, 2023 EX-10.14

Form of Restricted Stock Agreement (Directors) #1

EXHIBIT 10.14 CENTENE CORPORATION Restricted Stock Agreement Granted Under 2012 Stock Incentive Plan THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and the undersigned Director of the Company (hereinafter the “Participant”). WHEREAS, the Company desires to align the long-term interests of its directors with those of the Company by providi

February 21, 2023 EX-21

List of subsidiaries

EXHIBIT 21 List of Subsidiaries ABC Network & Collaborative Health Systems Joint Venture, LLC, an Arizona LLC Absolute Total Care, Inc, a South Carolina corporation AcariaHealth Pharmacy #11, Inc, a Texas corporation AcariaHealth Pharmacy #12, Inc, a New York corporation AcariaHealth Pharmacy #13, Inc, a California corporation AcariaHealth Pharmacy #14, Inc, a California corporation AcariaHealth Pharmacy #26, Inc, a Delaware corporation AcariaHealth Pharmacy, Inc, a California corporation AcariaHealth Solutions, Inc.

February 21, 2023 EX-4.1

Description of Securities of the Company

EXHIBIT 4.1 DESCRIPTION OF CENTENE COMMON STOCK Authorized Capital Stock of Centene The Centene amended and restated certificate of incorporation provides that the total number of shares of capital stock which may be issued by Centene is 810,000,000, consisting of 800,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share. V

February 21, 2023 EX-10.13

Form of Non-statutory Stock Option Agreement (Directors)

EXHIBIT 10.13 CENTENE CORPORATION Nonstatutory Stock Option Agreement Granted Under 2012 Stock Incentive Plan 1.Grant of Option This agreement evidences the grant by Centene Corporation, a Delaware corporation (the “Company”), on (the “Grant Date”) to , a Director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 20

February 21, 2023 EX-10.23A

Amendment of Executive Employment Agreement between Centene Corporation and Andrew Asher, dated February 20, 2023

EXHIBIT 10.23a AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT (the “Amendment”) is entered into as of February 20, 2023, by and between Centene Corporation, a Delaware corporation, together with its successors and assigns permitted under this Agreement (the “Company”), and Andrew Asher (the “Executive”). WHEREAS, the parties entered into that certain E

February 13, 2023 SC 13G/A

CNC / Centene Corp / Capital World Investors - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Centene Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 15135B101 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig

February 9, 2023 SC 13G/A

CNC / Centene Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Centene Corp. Title of Class of Securities: Common Stock CUSIP Number: 15135B101 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule

February 7, 2023 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2023 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

February 7, 2023 EX-99.1

CENTENE CORPORATION REPORTS 2022 RESULTS -- 2022 Full Year Diluted EPS of $2.07; Adjusted Diluted EPS of $5.78 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Sandy McBride Senior Vice President, Finance & Investor Relations Vice President, Media & Public Relations (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS 2022 RESULTS - 2022 Full Year Diluted EPS of $2.07; Adjusted Diluted EPS of $5.78 - •2022 adjusted diluted

December 16, 2022 EX-99.1

CENTENE CORPORATION ANNOUNCES 2023 GUIDANCE

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Suzy Deprizio Senior Vice President, Finance & Investor Relations Chief Marketing & Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION ANNOUNCES 2023 GUIDANCE •2023 Adjusted Diluted EPS of $6.25 to $6.40 •Announces Long-Term Adjusted Diluted EPS CAG

December 16, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2022 CENTENE CORPORA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

December 14, 2022 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

December 14, 2022 EX-10.1

Amendment of Executive Employment Agreement between Centene Corporation and Brent Layton dated December 13, 2022

EXHIBIT 10.1 AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT (the ?Amendment?) is entered into as of December 13, 2022, by and between Centene Corporation, a Delaware corporation, together with its successors and assigns permitted under this Agreement (the ?Company?), and Brent Layton (the ?Executive?). WHEREAS, the parties entered into that certain Exe

December 14, 2022 EX-99.1

CENTENE CORPORATION ANNOUNCES LEADERSHIP CHANGES AND APPOINTMENTS FOR NEXT PHASE OF GROWTH Ken Fasola named President of Centene Jim Murray named Chief Operating Officer Brent Layton becomes Senior Advisor to the CEO Dave Thomas becomes Chief Executi

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Suzy Deprizio Senior Vice President, Finance & Investor Relations Chief Marketing & Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION ANNOUNCES LEADERSHIP CHANGES AND APPOINTMENTS FOR NEXT PHASE OF GROWTH Ken Fasola named President of Centene Jim M

November 16, 2022 EX-99.1

Contacts: Media Investors Suzy DePrizio Jennifer Gilligan (314) 445-0790 (212) 549-1306 [email protected] [email protected]

Exhibit 99.1 N E W S R E L E A S E Contacts: Media Investors Suzy DePrizio Jennifer Gilligan (314) 445-0790 (212) 549-1306 [email protected] [email protected] FOR IMMEDIATE RELEASE CENTENE APPOINTS MONTE FORD BOARD OF DIRECTORS ST. LOUIS (November 16, 2022) ? Centene Corporation (NYSE: CNC) announced today that it has appointed Monte Ford to the Centene Board of Directors, effective N

November 16, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

October 25, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

October 25, 2022 EX-99.1

CENTENE CORPORATION REPORTS THIRD QUARTER 2022 RESULTS -- Diluted EPS of $1.27; Adjusted Diluted EPS of $1.30 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Suzy Deprizio Senior Vice President, Finance & Investor Relations Chief Marketing & Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS THIRD QUARTER 2022 RESULTS - Diluted EPS of $1.27; Adjusted Diluted EPS of $1.30 - ?Total revenues up 11%

October 25, 2022 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

September 30, 2022 EX-3.2

Amended and Restated By-laws of Centene Corporation, effective September 27, 2022

Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF CENTENE CORPORATION A Delaware Corporation Effective September 27, 2022 TABLE OF CONTENTS ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 1. Place of Meetings 1 Section 2. Annual Meetings 1 Section 3. Special Meetings 1 Section 4. Quorum 4 Section 5. Proxies 4 Section 6. Voting 5

September 30, 2022 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

September 30, 2022 EX-3.1

Amended and Restated Certificate of Incorporation of Centene Corporation, dated September 27, 2022

Exhibit 3.1 AMENDED AND RESTATED CENTENE CORPORATION CERTIFICATE OF INCORPORATION Centene Corporation, a Delaware corporation (hereinafter called the ?Corporation?), does hereby certify as follows: (1)The Corporation?s original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on September 26, 2001. (2)This Amended and Restated Certificate of Incorporation

August 11, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: o Preliminary Proxy Statement o Confide

August 1, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEFA14A 1 a20220801defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as

August 1, 2022 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: x Preliminary Proxy Statement o Confide

July 26, 2022 EX-99.1

CENTENE CORPORATION REPORTS SECOND QUARTER 2022 RESULTS -- Diluted Loss Per Share of $(0.29), including real estate charge; Adjusted Diluted EPS of $1.77 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Suzy Deprizio Senior Vice President, Finance & Investor Relations Chief Marketing & Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS SECOND QUARTER 2022 RESULTS - Diluted Loss Per Share of $(0.29), including real estate charge; Adjusted Di

July 26, 2022 EX-10.1

Executive Employment Agreement between Centene Corporation and Sarah M. London, dated April 27, 2022

EXHIBIT 10.1 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?) is made as of April 27, 2022, by and between Centene Corporation (together with its successors and assigns, the ?Company?), and Sarah M. London (?Executive?). R E C I T A L S WHEREAS, the Company desires to continue to employ Executive as the Company?s Chief Executive Officer; and WHEREAS, the Company and

July 26, 2022 EX-10.3

Executive Employment Agreement between Centene Corporation and Andrew Asher, dated April 28, 2022

EXHIBIT 10.3 EXECUTIVE EMPLOYMENT AGREEMENT In this Executive Employment Agreement, dated as of April 28, 2022 (the ?Agreement?), Centene Corporation (the ?Company?), and Andrew Asher (the ?Executive?), intending to be legally bound and for good and valuable consideration, agree as follows: 1.Term. a.The Executive?s employment hereunder shall begin on January 1, 2022 and shall continue until Decem

July 26, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

July 26, 2022 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

July 26, 2022 EX-10.2

Executive Employment Agreement between Centene Corporation and Brent Layton, dated April 27, 2022

EXHIBIT 10.2 EXECUTIVE EMPLOYMENT AGREEMENT In this Executive Employment Agreement, dated as of April 27, 2022 (the ?Agreement?), Centene Corporation (the ?Company?), and Brent Layton (the ?Executive?), intending to be legally bound and for good and valuable consideration, agree as follows: 1.Term. a.The Executive?s employment hereunder shall begin on January 1, 2022 and shall continue until Decem

June 17, 2022 EX-99.1

CENTENE CORPORATION ANNOUNCES INCREASED 2022 GUIDANCE AND VALUE CREATION UPDATES

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Suzy Deprizio Senior Vice President, Finance & Investor Relations Chief Marketing & Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION ANNOUNCES INCREASED 2022 GUIDANCE AND VALUE CREATION UPDATES ?2022 Adjusted Diluted EPS of $5.55 to $5.70 ?Reduces

June 17, 2022 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

May 2, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

April 28, 2022 EX-3.2

Amended and Restated By-laws of Centene Corporation, effective April 26, 2022.

Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF CENTENE CORPORATION A Delaware Corporation Effective April 26, 2022 TABLE OF CONTENTS ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 1. Place of Meetings 1 Section 2. Annual Meetings 1 Section 3. Special Meetings 1 Section 4. Quorum 2 Section 5. Proxies 2 Section 6. Voting 3 Sec

April 28, 2022 EX-3.1

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Centene Corporation, dated April 26, 2022.

Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CENTENE CORPORATION Centene Corporation (the ?Corporation?), a corporation organized and existing under the laws and by virtue of the General Corporation Law of the State of Delaware (the ?GCL?), DOES, HEREBY CERTIFY: 1.This Certificate of Amendment (the ?Certificate of Amendment?) amends the Amended a

April 28, 2022 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

April 26, 2022 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

April 26, 2022 EX-99.1

CENTENE CORPORATION REPORTS FIRST QUARTER 2022 RESULTS AND INCREASES 2022 GUIDANCE -- Diluted EPS of $1.44; Adjusted Diluted EPS of $1.83 -- -- Raises Total Revenue and Adjusted EPS Guidance --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Marcela Manjarrez-Hawn Senior Vice President, Finance & Investor Relations Executive Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS FIRST QUARTER 2022 RESULTS AND INCREASES 2022 GUIDANCE - Diluted EPS of $1.44; Adju

April 26, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

April 15, 2022 EX-99.1

CENTENE BOARD ISSUES STATEMENT ON DEPARTURE OF BOARD MEMBER

Exhibit 99.1 N E W S R E L E A S E Contact: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 549-1306 [email protected] [email protected] FOR IMMEDIATE RELEASE CENTENE BOARD ISSUES STATEMENT ON DEPARTURE OF BOARD MEMBER ST. LOUIS (April 15, 2022) - Centene Corporation?s (NYSE: CNC) Board of Directors issued the following statement today: The Centene

April 15, 2022 DEFR14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1)

DEFR14A 1 a20220415defr14asupplement.htm DEFR14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commissi

April 15, 2022 EX-17.1

Letter, dated April 11, 2022, Leslie Norwalk to the Board of Directors of Centene Corporation

Exhibit 17.1 Leslie V. Norwalk, Esq. 1227 25th St. NW Washington, NC 20037 April 11, 2022 Acting Chair of the Board H. James Dallas Chair of the Nominating and Governance Committee Jessica Blume Members of the Board of Directors Centene Corporation 7700 Forsyth Boulevard St. Louis, MO 63105 Dear James, Jessica, and fellow Members of the Board, As we have discussed, and without regard to the merits

April 15, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

March 31, 2022 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (C

March 31, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

March 23, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

March 22, 2022 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Num

March 22, 2022 EX-99.1

CENTENE APPOINTS SARAH LONDON AS CHIEF EXECUTIVE OFFICER

Exhibit 99.1 N E W S R E L E A S E Contacts: Media Investors Marcela Manjarrez Jennifer Gilligan (314) 445-0790 (212) 459-1306 [email protected] [email protected] CENTENE APPOINTS SARAH LONDON AS CHIEF EXECUTIVE OFFICER ST. LOUIS (March 22, 2022) - Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, e

March 18, 2022 PX14A6G

Centene Corporation (CNC)

Centene Corporation (CNC) Shareholder Alert Voluntary submission by John Chevedden, POB 2673, Redondo Beach, CA 90278 Centene Shareholder since 2019 Please vote for Shareholder Proposal 6 for a Shareholder Right to Call a Special Shareholder Meeting and Against the Management Come-Lately Blank-Check Non-Binding Proposal 5 in Competition for Your Vote Centene shareholders now have no right to call a special shareholder meeting in spite of this being a widespread right for shareholders at hundreds of S&P 500 companies.

March 11, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide

March 11, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide

March 1, 2022 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confide

February 24, 2022 EX-99.1

Media Investors Marcela Manjarrez Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected]

Exhibit 99.1 N E W S R E L E A S E Media Investors Marcela Manjarrez Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] FOR IMMEDIATE RELEASE CENTENE ANNOUNCES APPROVAL OF REQUEST BY MICHAEL NEIDORFF, CHAIRMAN & CEO, TO TAKE A MEDICAL LEAVE OF ABSENCE ~James Dallas Appointed Acting Chairman of the Board of Directors~ ~Company to be led on interim

February 24, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

February 22, 2022 EX-10.31

Separation Agreement and General Release between Centene Management Company LLC and Jesse N. Hunter, dated November 5, 2021

Exhibit 10.31 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (?Release?) is made by and between Centene Management Company LLC (?Company?) and Jesse N. Hunter, the individual signing below (?Employee?). In consideration of the mutual promises, covenants, and agreements contained in this Release, the adequacy and sufficiency of which are hereby acknowledged,

February 22, 2022 EX-10.8G

Amendment No 7. of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff

EXHIBIT 10.8g AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT is entered into as of October 26, 2021, by and between Centene Corporation, a Delaware corporation, together with its successors and assigns permitted under this Agreement (?Employer?), and Michael F. Neidorff (the ?Executive?). WHEREAS, the parties entered into that certain Executive Employm

February 22, 2022 EX-4.1

Description of Securities of the Company

Exhibit 4.1 DESCRIPTION OF CENTENE COMMON STOCK Authorized Capital Stock of Centene The Centene amended and restated certificate of incorporation provides that the total number of shares of capital stock which may be issued by Centene is 810,000,000, consisting of 800,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share. V

February 22, 2022 EX-10.30

Transition Agreement between Centene Corporation and Jesse Hunter, dated October 26, 2021

EXHIBIT 10.30 October 26, 2021 Jesse Hunter Dear Jesse: At your request, we have summarized our understanding of the termination of your employment effective November 5, 2021 with Centene Management Corporation (?Centene?) based on the following terms set forth in this letter agreement (the ?Agreement?). 1.Term: We confirm you will remain an active employee available to provide transition support

February 22, 2022 EX-10.12

Form of Non-statutory Stock Option Agreement (Employees) #2

EXHIBIT 10.12 CENTENE CORPORATION Nonstatutory Stock Option Agreement Granted Under 2012 Stock Incentive Plan, as amended THIS AGREEMENT is entered into by and between CENTENE CORPORATION, a Delaware corporation (hereinafter the ?Company?), and the undersigned employee of the Company (hereinafter the ?Participant?). WHEREAS, the Participant renders important services to the Company and acquires ac

February 22, 2022 EX-10.8H

Amendment No.8 of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff

EXHIBIT 10.8h AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT is entered into as of December 14, 2021 by and between Centene Corporation, a Delaware corporation, together with its successors and assigns permitted under this Agreement (?Employer?), and Michael F. Neidorff (the ?Executive?). WHEREAS, the parties entered into that certain Executive Employm

February 22, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 Centene Corpor

February 22, 2022 EX-21

List of subsidiaries

Exhibit 21 List of Subsidiaries Absolute Total Care, Inc., a South Carolina corporation AcariaHealth Pharmacy #11, Inc., a Texas corporation AcariaHealth Pharmacy #12, Inc., a New York corporation AcariaHealth Pharmacy #13, Inc., a California corporation AcariaHealth Pharmacy #14, Inc., a California corporation AcariaHealth Pharmacy #26, Inc., a Delaware corporation AcariaHealth Pharmacy, Inc., a

February 11, 2022 SC 13G/A

CNC / Centene Corp / Capital World Investors - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Centene Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 15135B101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

February 9, 2022 SC 13G/A

CNC / Centene Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Centene Corp. Title of Class of Securities: Common Stock CUSIP Number: 15135B101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule

February 8, 2022 EX-99.1

CENTENE CORPORATION REPORTS 2021 RESULTS -- 2021 Full Year Diluted EPS of $2.28; Adjusted Diluted EPS of $5.15 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Marcela Manjarrez-Hawn Senior Vice President, Finance & Investor Relations Executive Vice President, Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS 2021 RESULTS - 2021 Full Year Diluted EPS of $2.28; Adjusted Diluted EPS of $5.15 -

February 8, 2022 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

January 11, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

January 11, 2022 EX-99.1

LESLIE NORWALK APPOINTED TO CENTENE BOARD OF DIRECTORS

Exhibit 99.1 N E W S R E L E A S E Contact: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 549-1306 [email protected] [email protected] FOR IMMEDIATE RELEASE LESLIE NORWALK APPOINTED TO CENTENE BOARD OF DIRECTORS ST. LOUIS (January 11, 2022) ? Today, Centene announced Leslie V. Norwalk, Esq. has been appointed to the Centene Board of Directors. Ms.

January 4, 2022 EX-99.1

Centene Completes Acquisition of Magellan Health, Establishing a Leading Behavioral Health Platform at a Critical Time

Exhibit 99.1 N E W S R E L E A S E Contacts: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] Centene Completes Acquisition of Magellan Health, Establishing a Leading Behavioral Health Platform at a Critical Time ST. LOUIS (January 4, 2022) - Centene Corporation (NYSE: CNC) today announced that it has comp

January 4, 2022 S-8

As filed with the Securities and Exchange Commission on January 4, 2022

As filed with the Securities and Exchange Commission on January 4, 2022 Registration No.

January 4, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Nu

January 4, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2022 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Nu

January 4, 2022 424B5

CALCULATION OF REGISTRATION FEE

TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No. 333-238050 CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered ? ? Amount to be Registered ? ? Proposed Maximum Offering Price Per Share(3) ? ? Proposed Maximum Aggregate Offering Price ? ? Amount of Registration Fee(4) Common stock, par value $0.001 per share ? ? 347,468(1) ? ? $83.255 ? ? $28,928,4

December 14, 2021 EX-10.1

[Signature Pages Follow]

Exhibit 10.1 Centene Plaza 7700 Forsyth Boulevard St. Louis, Missouri 63105 December 14, 2021 Politan Capital Management LP Attention: Quentin Koffey c/o Schulte Roth & Zabel LLP 919 Third Avenue, Suite 2300 New York, NY 10022 Email: [email protected] Re: Cooperation Agreement Ladies and Gentlemen: In consideration of the representations, warranties, covenants and agreements in this letter a

December 14, 2021 EX-3.1

By-laws of Centene Corporation, as amended and restated effective as of December 14, 2021

Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF CENTENE CORPORATION A Delaware Corporation Effective December 14, 2021 TABLE OF CONTENTS ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 1. Place of Meetings 1 Section 2. Annual Meetings 1 Section 3. Special Meetings 1 Section 4. Quorum 2 Section 5. Proxies 2 Section 6. Voting 3

December 14, 2021 EX-3.1

AMENDED AND RESTATED BY-LAWS CENTENE CORPORATION A Delaware Corporation Effective December 14, 2021 TABLE OF CONTENTS

Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF CENTENE CORPORATION A Delaware Corporation Effective December 14, 2021 TABLE OF CONTENTS ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 1. Place of Meetings 1 Section 2. Annual Meetings 1 Section 3. Special Meetings 1 Section 4. Quorum 2 Section 5. Proxies 2 Section 6. Voting 3

December 14, 2021 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

December 14, 2021 EX-99.1

CENTENE ANNOUNCES GOVERNANCE AND BOARD OF DIRECTORS CHANGES

Exhibit 99.1 N E W S R E L E A S E Contacts: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] CENTENE ANNOUNCES GOVERNANCE AND BOARD OF DIRECTORS CHANGES Five New Directors to Join the Board James Dallas to Become Independent Chairman in 2022 and Lead Independent Director Immediately Centene and Politan Ca

December 14, 2021 EX-10.1

[Signature Pages Follow]

Exhibit 10.1 Centene Plaza 7700 Forsyth Boulevard St. Louis, Missouri 63105 December 14, 2021 Politan Capital Management LP Attention: Quentin Koffey c/o Schulte Roth & Zabel LLP 919 Third Avenue, Suite 2300 New York, NY 10022 Email: [email protected] Re: Cooperation Agreement Ladies and Gentlemen: In consideration of the representations, warranties, covenants and agreements in this letter a

December 14, 2021 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2021 CENTENE CORPORA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

December 14, 2021 EX-99.2

CENTENE ANNOUNCES LEADERSHIP SUCCESSION PLAN

Exhibit 99.2 N E W S R E L E A S E Contacts: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] CENTENE ANNOUNCES LEADERSHIP SUCCESSION PLAN ST. LOUIS (December 14, 2021) ? Centene Corporation (NYSE: CNC) (?Centene?) today announced Chairman and CEO Michael Neidorff?s intent to retire in 2022 as CEO. Upon hi

December 14, 2021 EX-99.1

CENTENE ANNOUNCES GOVERNANCE AND BOARD OF DIRECTORS CHANGES

Exhibit 99.1 N E W S R E L E A S E Contacts: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] CENTENE ANNOUNCES GOVERNANCE AND BOARD OF DIRECTORS CHANGES Five New Directors to Join the Board James Dallas to Become Independent Chairman in 2022 and Lead Independent Director Immediately Centene and Politan Ca

December 14, 2021 EX-99.2

CENTENE ANNOUNCES LEADERSHIP SUCCESSION PLAN

Exhibit 99.2 N E W S R E L E A S E Contacts: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] CENTENE ANNOUNCES LEADERSHIP SUCCESSION PLAN ST. LOUIS (December 14, 2021) ? Centene Corporation (NYSE: CNC) (?Centene?) today announced Chairman and CEO Michael Neidorff?s intent to retire in 2022 as CEO. Upon hi

December 10, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

December 10, 2021 EX-99.1

CENTENE CORPORATION ANNOUNCES 2022 GUIDANCE AND DETAILS VALUE CREATION PLAN -- 2024 Adjusted Diluted EPS Targets to be Detailed at Investor Day --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Marcela Manjarrez-Hawn Senior Vice President, Finance & Investor Relations Senior Vice President and Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION ANNOUNCES 2022 GUIDANCE AND DETAILS VALUE CREATION PLAN - 2024 Adjusted Diluted EPS Targets

October 29, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

October 26, 2021 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File N

October 26, 2021 EX-10.2

Separation Agreement and Release between Centene Corporation and Jeffrey Schwaneke, dated September 26, 2021.

Exhibit 10.2 SEPARATION AGREEMENT AND RELEASE THIS SEPARATION AGREEMENT AND RELEASE (this ?Agreement?) is entered into by and between Centene Corporation (the ?Company?) and Jeffrey Schwaneke (?Executive?), dated September 26, 2021. The Company and Executive may be referred to herein individually as a ?Party? and collectively as the ?Parties.? WITNESSETH: WHEREAS, the Company and Executive are par

October 26, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

October 26, 2021 EX-99.1

CENTENE CORPORATION REPORTS THIRD QUARTER 2021 RESULTS -- Diluted EPS Per Share of $0.99; Adjusted Diluted EPS of $1.26 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Marcela Manjarrez-Hawn Senior Vice President, Finance & Investor Relations Senior Vice President and Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS THIRD QUARTER 2021 RESULTS - Diluted EPS Per Share of $0.99; Adjusted Diluted EPS o

October 8, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Nu

October 8, 2021 EX-99.1

DAVID STEWARD RETIRES FROM CENTENE’S BOARD OF DIRECTORS

Exhibit 99.1 N E W S R E L E A S E Contact: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] FOR IMMEDIATE RELEASE DAVID STEWARD RETIRES FROM CENTENE?S BOARD OF DIRECTORS ST. LOUIS (October 8, 2021) ? Centene Corporation (NYSE: CNC) today announced that David L. Steward has retired from Centene?s Board of

September 27, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

September 7, 2021 EX-3.1

Amended and Restated By-Laws of Centene Corporation, as amended effective as of September 7, 2021.

Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF CENTENE CORPORATION A Delaware Corporation Effective September 7, 2021 TABLE OF CONTENTS ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 1. Place of Meetings 1 Section 2. Annual Meetings 1 Section 3. Special Meetings 1 Section 4. Quorum 2 Section 5. Proxies 2 Section 6. Voting 3

September 7, 2021 EX-99.1

CENTENE’S BOARD OF DIRECTORS APPOINTS SARAH LONDON AS VICE CHAIRMAN BRENT LAYTON NAMED PRESIDENT AND CHIEF OPERATING OFFICER

Exhibit 99.1 N E W S R E L E A S E Contact: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] FOR IMMEDIATE RELEASE CENTENE?S BOARD OF DIRECTORS APPOINTS SARAH LONDON AS VICE CHAIRMAN BRENT LAYTON NAMED PRESIDENT AND CHIEF OPERATING OFFICER ST. LOUIS (September 7, 2021) ? Centene today announced two key app

September 7, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File

August 18, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Nu

August 18, 2021 EX-1.1

FOURTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of August 16, 2021 CENTENE CORPORATION, as the Company, THE VARIOUS FINANCIAL INSTITUTIONS PARTY HERETO, as Lenders, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent WELLS FARGO SEC

Exhibit 1.1 EXECUTION COPY FOURTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of August 16, 2021 among CENTENE CORPORATION, as the Company, THE VARIOUS FINANCIAL INSTITUTIONS PARTY HERETO, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent WELLS FARGO SECURITIES, LLC and BOFA SECURITIES, INC., JPMORGAN CHASE BANK, N.A., TRUIST SECURITIES, INC., BARCLAYS BANK PLC and

August 12, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Nu

August 12, 2021 EX-4.4

Fourth Supplemental Indenture, dated as of August 12, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee

Exhibit 4.4 CENTENE CORPORATION as Issuer $1,300,000,000 2.625% Senior Notes due 2031 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee FOURTH SUPPLEMENTAL INDENTURE Dated as of August 12, 2021 TO THE INDENTURE Dated as of October 7, 2020 TABLE OF CONTENTS Page ARTICLE 1 APPLICATION OF SUPPLEMENTAL INDENTURE AND DEFINITIONS Section 1.01. Application of this Supplemental Indenture. 1 Secti

July 30, 2021 FWP

2.450% Senior Notes due 2028 2.625% Senior Notes due 2031 July 29, 2021

Issuer Free Writing Prospectus dated July 29, 2021 Filed pursuant to Rule 433(d) Registration Statement No.

July 30, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

July 30, 2021 EX-1.1

$1,800,000,000 Centene Corporation $500,000,000 2.450% Senior Notes due 2028 $1,300,000,000 2.625% Senior Notes due 2031 Underwriting Agreement

Exhibit 1.1 $1,800,000,000 Centene Corporation $500,000,000 2.450% Senior Notes due 2028 $1,300,000,000 2.625% Senior Notes due 2031 Underwriting Agreement July 29, 2021 J.P. MORGAN SECURITIES LLC 383 MADISON AVENUE NEW YORK, NY 10179 As Representative of the several Underwriters named in Schedule I hereto Ladies and Gentlemen: Centene Corporation, a Delaware corporation (the ?Company?), proposes

July 30, 2021 EX-99.2

Centene Corporation Prices Offering of Senior Notes

Exhibit 99.2 N E W S R E L E A S E Centene Corporation Prices Offering of Senior Notes ST. LOUIS (July 29, 2021) ? Centene Corporation (NYSE: CNC) (?Centene? or the ?Company?) announced today that it has priced its previously announced underwritten public offering of $1,800,000,000 aggregate principal amount of senior notes. The $1,800,000,000 offering of senior notes will include $500,000,000 agg

July 30, 2021 424B5

Title of Each Class of Securities to be Registered

TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No. 333-238050 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered ? ? Amount to be Registered ? ? Proposed Maximum Aggregate Offering Price Per Unit ? ? Proposed Maximum Aggregate Offering Price ? ? Amount of Registration Fee(1) 2.450% Notes due 2028 ? ? $500,000,000 ? ? 100.875% ? ? $504,375,000 ? ? $5

July 30, 2021 EX-99.1

Centene Corporation Announces Offering of Senior Notes

Exhibit 99.1 N E W S R E L E A S E Centene Corporation Announces Offering of Senior Notes ST. LOUIS (July 29, 2021) ? Centene Corporation (NYSE: CNC) (?Centene? or the ?Company?) announced today that it has commenced an underwritten public offering to sell $1,800,000,000 of senior notes. The $1,800,000,000 offering of senior notes will include an add-on to its 2.450% senior notes due 2028 (the ?20

July 29, 2021 424B5

Per Additional 2.450% 2028 Note

TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No. 333-238050 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. A registration statement relating to the securitieshas become effective. This preliminary prospectus supplement and accompanying prospectus are not offers to sell these securities, and we are not

July 27, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 CENTENE CORPORATION (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of (I.

July 27, 2021 EX-99.1

CENTENE CORPORATION REPORTS SECOND QUARTER 2021 RESULTS -- Diluted Loss Per Share of $(0.92); Adjusted Diluted EPS of $1.25 --

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Marcela Manjarrez-Hawn Senior Vice President, Finance & Investor Relations Senior Vice President and Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS SECOND QUARTER 2021 RESULTS - Diluted Loss Per Share of $(0.92); Adjusted Diluted E

July 27, 2021 8-K

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

July 27, 2021 EX-10.2

Letter Agreement, dated May 4, 2021, by and between Centene Corporation and Andrew Asher

Exhibit 10.2 May 4, 2021 Andrew L. Asher Dear Drew: Please accept this as the terms of our offer for your promotion with Centene effective May 7, 2021. The general terms are as follows: 1.The position offered is Executive Vice President, CFO, reporting to Michael F. Neidorff. 2.Your compensation will consist of a base salary of $975,000 per annum, plus an annual bonus target of 100% of eligible ea

July 15, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

July 15, 2021 EX-99.1

CENTENE NAMES COLIN TONEY EXECUTIVE VICE PRESIDENT, MERGERS AND ACQUISITIONS

Exhibit 99.1 N E W S R E L E A S E Contact: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] FOR IMMEDIATE RELEASE CENTENE NAMES COLIN TONEY EXECUTIVE VICE PRESIDENT, MERGERS AND ACQUISITIONS ST. LOUIS (July 15, 2021) ? Centene Corporation (NYSE: CNC) today announced that Colin Toney, Senior Vice President

July 1, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

July 1, 2021 EX-4.2

CENTENE CORPORATION as Issuer 2.450% Senior Notes due 2028 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee THIRD SUPPLEMENTAL INDENTURE Dated as of July 1, 2021 TO THE INDENTURE Dated as of October 7, 2020 TABLE OF CONTENTS

Exhibit 4.2 CENTENE CORPORATION as Issuer $1,800,000,000 2.450% Senior Notes due 2028 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee THIRD SUPPLEMENTAL INDENTURE Dated as of July 1, 2021 TO THE INDENTURE Dated as of October 7, 2020 TABLE OF CONTENTS Page ARTICLE 1 APPLICATION OF SUPPLEMENTAL INDENTURE AND DEFINITIONS Section 1.01. Application of this Supplemental Indenture. 1 Section 1

June 25, 2021 EX-1.1

$1,800,000,000 Centene Corporation $1,800,000,000 2.450% Senior Notes due 2028 Underwriting Agreement

Exhibit 1.1 $1,800,000,000 Centene Corporation $1,800,000,000 2.450% Senior Notes due 2028 Underwriting Agreement June 24, 2021 J.P. Morgan Securities LLC 383 Madison Avenue New York, NY 10179 As Representative of the several Underwriters named in Schedule I hereto Ladies and Gentlemen: Centene Corporation, a Delaware corporation (the ?Company?), proposes to issue and sell $1,800,000,000 principal

June 25, 2021 424B5

CALCULATION OF REGISTRATION FEE

TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No. 333-238050 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered ? ? Amount to be Registered ? ? Proposed Maximum Aggregate Offering Price Per Unit ? ? Proposed Maximum Aggregate Offering Price ? ? Amount of Registration Fee(1) 2.450% Notes due 2028 ? ? $1,800,000,000 ? ? 100.00% ? ? $1,800,000,000 ? ?

June 25, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

June 25, 2021 EX-99.2

Centene Corporation Prices Offering of Senior Notes

Exhibit 99.2 N E W S R E L E A S E Centene Corporation Prices Offering of Senior Notes ST. LOUIS (June 24, 2021) ? Centene Corporation (NYSE: CNC) (?Centene? or the ?Company?) announced today that it has priced its previously announced underwritten public offering of $1,800,000,000 aggregate principal amount of 2.450% senior notes due 2028 (the ?Notes?). The offering is expected to close on or abo

June 25, 2021 EX-99.1

Centene Corporation Announces Offering of Senior Notes

Exhibit 99.1 N E W S R E L E A S E Centene Corporation Announces Offering of Senior Notes ST. LOUIS (June 24, 2021) ? Centene Corporation (NYSE: CNC) (?Centene? or the ?Company?) announced today that it has commenced an underwritten public offering to sell $1,800,000,000 of senior notes due 2028 (the ?Notes?), subject to market and other conditions. Centene intends to use the net proceeds from the

June 24, 2021 424B5

Subject to Completion, dated June 24, 2021

TABLE OF CONTENTS The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed.

June 24, 2021 FWP

2.450% Senior Notes due 2028 June 24, 2021

Issuer Free Writing Prospectus dated June 24, 2021 Filed pursuant to Rule 433(d) Registration Statement No.

June 14, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2021 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Numb

June 14, 2021 EX-99.1

Centene Reaches No-Fault Agreements with Ohio and Mississippi to Resolve Pharmacy Subsidiary Claims Sets Reserve to Resolve Similar Concerns in All Other Affected States

Exhibit 99.1 N E W S R E L E A S E Contact: Media Investors Marcela Manjarrez-Hawn Jennifer Lynch Gilligan (314) 445-0790 (212) 759-0382 [email protected] [email protected] FOR IMMEDIATE RELEASE Centene Reaches No-Fault Agreements with Ohio and Mississippi to Resolve Pharmacy Subsidiary Claims Sets Reserve to Resolve Similar Concerns in All Other Affected States ST. LOUIS (June 14, 20

Other Listings
IT:1CNC € 24.40
MX:CNC
GB:0HVB US$ 28.84
DE:QEN € 24.45
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista